Dental Care Clinics in Holbrook, NY Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Kiddsmiles Dds 3 Pllc Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 315 Main St Ste 315-i, Holbrook, NY 11741 Phone: 631-254-5437 Fax: 631-676-4071 |
Bracetown Holbrook Orthodontics. Llp Dentist Medicare: Not Enrolled in Medicare Practice Location: 264 Union Ave, Holbrook, NY 11741 Phone: 631-588-5600 |
K Jayadevan Dds Dentist Medicare: Not Enrolled in Medicare Practice Location: 5801 Sunrise Hwy, Holbrook, NY 11741 Phone: 631-567-8899 Fax: 631-567-8118 |
Greg B. Cinski Dmd., Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 900 Main St, Suite 104, Holbrook, NY 11741 Phone: 631-981-5600 Fax: 631-981-5637 |
News Archive
Endoscopic treatment with polydimethylsiloxane in children with dilating vesico-ureteric reflux
This group from Italy assessed their endoscopic treatment of dilating vesico-ureteric reflux (VUR) in children with polydimethylsiloxane (MacroplastiqueTM, MPQ; Uroplasty BV, Geleen, The Netherlands).
Interim results from CTI, Chroma Therapeutics' tosedostat phase II trial on AML presented at ASCO
Cell Therapeutics, Inc. and Chroma Therapeutics Ltd. announced that interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) were presented by Jorge Cortes, M.D. and discussed at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) by Farhad Ravandi, M.D., who presided over the ASCO discussion session, both of the University of Texas M.D. Anderson Cancer Center.
Essential worker shoulders $1,840 pandemic debt due to COVID cost loophole
Carmen Quintero works an early shift as a supervisor at a 3M distribution warehouse that ships N95 masks to a nation under siege from the coronavirus. On March 23, she had developed a severe cough, and her voice, usually quick and enthusiastic, was barely a whisper.
Oxford Finance leads $30 million credit facility provided to Cadence for launch of OFIRMEV
Oxford Finance Corporation, a subsidiary of Sumitomo Corporation, today announced that it was the lead lender for a $30 million credit facility provided to Cadence Pharmaceuticals. Silicon Valley Bank and GE Financial Services, Inc. also participated in the loan agreement. This infusion of capital will support the company's potential launch of their investigational product candidate, OFIRMEV™, an intravenous formulation of acetaminophen that is currently marketed in Europe for the treatment of acute pain and fever.
Seattle Genetics prices underwritten public offering of 10,000,000 shares of common stock
Seattle Genetics, today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a price to the public of $15.50 per share.
› Verified 9 days ago